APA (7th ed.) Citation

Khalid Al Sulaiman BCCCP, B., PharmD, M. A. A., PharmD, A. F. A., PharmD, H. A. B., PharmD, M. Y. A., PharmD, R. A. A., . . . PharmD, O. A. (2025, September). Evaluation of the Clinical Outcomes of Apixaban Use in Patients with Atrial Fibrillation and Uncontrolled Hypothyroidism: A Real-world Evidence. Clinical and Applied Thrombosis/Hemostasis.

Chicago Style (17th ed.) Citation

Khalid Al Sulaiman BCCCP, BCNSP, et al. "Evaluation of the Clinical Outcomes of Apixaban Use in Patients with Atrial Fibrillation and Uncontrolled Hypothyroidism: A Real-world Evidence." Clinical and Applied Thrombosis/Hemostasis Sep. 2025.

MLA (9th ed.) Citation

Khalid Al Sulaiman BCCCP, BCNSP, et al. "Evaluation of the Clinical Outcomes of Apixaban Use in Patients with Atrial Fibrillation and Uncontrolled Hypothyroidism: A Real-world Evidence." Clinical and Applied Thrombosis/Hemostasis, Sep. 2025.